Effect of Radium-223 Dichloride (Ra-223) on Hospitalisation: An Analysis From the Phase 3 Randomised Alpharadin in Symptomatic Prostate Cancer Patients (ALSYMPCA) Trial
European Journal of Cancer - United Kingdom
doi 10.1016/j.ejca.2016.10.020
Full Text
Open PDFAbstract
Available in full text
Date
January 1, 2017
Authors
Publisher
Elsevier BV